Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model

被引:50
|
作者
Sui, Ailing [1 ]
Chen, Xiuping [2 ]
Shen, Jikui [3 ,4 ]
Demetriades, Anna M. [5 ]
Yao, Yiyun [1 ]
Yao, Yixuan [1 ]
Zhu, Yanji [1 ]
Shen, Xi [1 ]
Xie, Bing [1 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Ophthalmol, Sch Med, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Ophthalmol, Shanghai, Peoples R China
[3] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MA USA
[4] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MA USA
[5] New York Presbyterian Hosp, Dept Ophthalmol, Weill Cornell Med, New York, NY USA
关键词
OCULAR COMPLICATIONS; BETA; PDGF; THERAPY; VEGF; DEGENERATION; MACROPHAGES; MECHANISMS; DEFICIENT; PERICYTES;
D O I
10.1038/s41419-020-03076-7
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Activation of the nucleotide-binding domain leucine-rich repeat and pyrin domain containing receptor 3 (NLRP3) inflammasome plays an important role in ocular neovascularization. In our study, we found that the expression and activation levels of NLRP3 inflammasome components, including NLRP3, an apoptosis-associated speck-like protein (ASC) containing caspase activation and recruitment domain (CARD) and caspase-1 (CAS1), were significantly upregulated. In addition, we found interleukin (IL)-1 beta activity increased while IL-18 activity decreased in the retinas of oxygen-induced ischemic retinopathy (OIR) mice. MCC950, an inhibitor of NLRP3, reversed the IL-1 beta /IL-18 activation pattern, inhibited the formation of retinal neovascularization (RNV), decreased the number of acellular capillaries and reduced leakage of retinal vessels. Moreover, MCC950 could regulate the expression of endothelial cell- and pericyte function-associated molecules, such as vascular endothelial growth factor (VEGF), VEGF receptor (VEGFR)1, VEGFR2, matrix metalloproteinase (MMP)2, MMP9, tissue inhibitor of metalloproteinases (TIMP)1, TIMP2, platelet-derived growth factor receptor-beta (PDGFR-beta), platelet-derived growth factor-B (PDGF-B), and angiopoietin2 (Ang2). In vitro, recombinant human (r)IL-18 and rIL-1 beta regulated the expression of endothelial cell- and pericyte function-associated molecules and the proliferation and migration of endothelial cells and pericytes. We therefore determined that inhibiting the NLRP3 inflammasome with MCC950 can regulate the function of endothelial cells and pericytes by reversing the IL-1 beta /IL-18 activation pattern to ameliorate RNV and leakage; thereby opening new avenues to treat RNV-associated ocular diseases.
引用
收藏
页数:16
相关论文
共 26 条
  • [1] Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model
    Ailing Sui
    Xiuping Chen
    Jikui Shen
    Anna M. Demetriades
    Yiyun Yao
    Yixuan Yao
    Yanji Zhu
    Xi Shen
    Bing Xie
    Cell Death & Disease, 11
  • [2] Distinct Licensing of IL-18 and IL-1β Secretion in Response to NLRP3 Inflammasome Activation
    Schmidt, Rebecca L.
    Lenz, Laurel L.
    PLOS ONE, 2012, 7 (09):
  • [3] MCC950 alleviates seizure severity and angiogenesis by inhibiting NLRP3/ IL-1β signaling pathway-mediated pyroptosis in mouse model of epilepsy
    Hong, Yongri
    Wei, Caichuan
    Fu, Miaoying
    Li, Xinyang
    Zhang, Haiju
    Yao, Baozhen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 126
  • [4] Effects of IL-1β and IL-18 induced by NLRP3 inflammasome activation on myocardial reperfusion injury after PCI
    Bai, Y. -J.
    Li, Z. -G.
    Liu, W. -H.
    Gao, D.
    Zhang, P. -Y.
    Liu, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (22) : 10101 - 10106
  • [5] Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death
    Matsuoka, Taisuke
    Yoshimatsu, Gumpei
    Sakata, Naoaki
    Kawakami, Ryo
    Tanaka, Tomoko
    Yamada, Teppei
    Yoshida, Yoichiro
    Hasegawa, Suguru
    Kodama, Shohta
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death
    Taisuke Matsuoka
    Gumpei Yoshimatsu
    Naoaki Sakata
    Ryo Kawakami
    Tomoko Tanaka
    Teppei Yamada
    Yoichiro Yoshida
    Suguru Hasegawa
    Shohta Kodama
    Scientific Reports, 10
  • [7] Elevated intracranial pressure induces IL-1β and IL-18 overproduction via activation of the NLRP3 inflammasome in microglia of ischemic adult rats
    Ding, Hongguang
    Li, Ya
    Wen, Miaoyun
    Liu, Xinqiang
    Han, Yongli
    Zeng, Hongke
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2021, 47 (01) : 183 - 194
  • [8] NLRP3 inflammasome-driven IL-1β and IL-18 contribute to lipopolysaccharide-induced septic cardiomyopathy
    Fujimura, Kenta
    Karasawa, Tadayoshi
    Komada, Takanori
    Yamada, Naoya
    Mizushina, Yoshiko
    Baatarjav, Chintogtokh
    Matsumura, Takayoshi
    Otsu, Kinya
    Takeda, Norihiko
    Mizukami, Hiroaki
    Kario, Kazuomi
    Takahashi, Masafumi
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2023, 180 : 58 - 68
  • [9] Inhibition of Microglial NLRP3 with MCC950 Attenuates Microglial Morphology and NLRP3/Caspase-1/IL-1β Signaling In Stress-induced Mice
    Liu, Qing
    Zhang, Man-Man
    Guo, Min-Xia
    Zhang, Qiu-Ping
    Li, Na-Zhi
    Cheng, Jie
    Wang, Shi-Le
    Xu, Guang-Hui
    Li, Cheng-Fu
    Zhu, Ji-Xiao
    Yi, Li-Tao
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2022, 17 (3-4) : 503 - 514
  • [10] Inhibition of Microglial NLRP3 with MCC950 Attenuates Microglial Morphology and NLRP3/Caspase-1/IL-1β Signaling In Stress-induced Mice
    Qing Liu
    Man-Man Zhang
    Min-Xia Guo
    Qiu-Ping Zhang
    Na-Zhi Li
    Jie Cheng
    Shi-Le Wang
    Guang-Hui Xu
    Cheng-Fu Li
    Ji-Xiao Zhu
    Li-Tao Yi
    Journal of Neuroimmune Pharmacology, 2022, 17 : 503 - 514